Authors: Reynders|, Kobe(1,2)*[kobereynders@gmail.com];Garg|, Abhishek D.(3);Van Limbergen|, Evert(1);Agostinis|, Patrizia(3);Vansteenkiste|, Johan(4);Hendriks|, Lizza(5);Rouschop|, Kasper(6);Rucevic|, Marijana(7);Lambrecht|, Maarten(8);De Ruysscher|, Dirk(1);
(1)MAASTRO- GROW School for Oncology and Developmental Biology- Maastricht University Medical Centre+, Department of Radiation Oncology, Maastricht, The Netherlands;(2)KU Leuven, Laboratory of Experimental Radiation Oncology, Leuven, Belgium;(3)KU Leuven, Laboratory for Cell Death Research and Therapy CDRT- Department of Cellular and Molecular Medicine, Leuven, Belgium;(4)University Hospitals KU Leuven, Respiratory Oncology Unit, Leuven, Belgium;(5)GROW School for Oncology and Developmental Biology- Maastricht University Medical Centre+, Department of Pulmonary Diseases, Maastricht, The Netherlands;(6)MAASTRO- GROW School for Oncology and Developmental Biology- Maastricht University Medical Centre+, Maastricht Radiation Oncology Lab, Maastricht, The Netherlands;(7)Olink Proteomics, Scientific Advisor, Watertown- MA, USA;(8)University Hospitals KU Leuven, Department of Radiation Oncology, Leuven, Belgium;
Show Affiliations
Hide Affiliations